Pharmacogenetic testing enables the possibility for a personalized approach to medication therapy by providing information about a patient’s likelihood to have a therapeutic response and/or an adverse reaction to a medication. For therapies such as chemotherapy, the potential for complications is very high and must be carefully weighed against the benefit and overall outcome for each patient. To minimize potential side effects, a patient’s genetic profile can help identify how they will metabolize and respond to the treatment. This white paper discusses pharmacogenetic testing and presents five things that should be understood about the process. Download the paper for more information on evolving treatments and drug designs, identifying safety and toxicity profiles, early therapy response monitoring, and more.